Global Gastric Cancer Testing Market Growth factors, Size, Share, Trends, Top Key Players Analysis 2013-2017, Forecast 2018-2024

15/giu/2018 15:06:02 Rajesh Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Gastric Cancer Testing Market: By Test (Immunohistochemistry (IHC), Fluorescent in situ hybridization (FISH)), By Product (Kits and Reagents), By Gastric Cancer type (Adenocarcinoma, Lymphoma, Gastrointestinal stromal tumor (GIST), and Carcinoid Tumor), By End User (Hospitals, Diagnostic Centers, and Others), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024


Global gastric cancer testing market was valued at US $ XX Mn and expected to grow at 5.0% Compound Annual Growth Rate (CAGR) over 2018 to 2024.


Market Outline: Gastric Cancer Testing Market

Cancer begins in the body when the cells in the body grow without any control. Cells present in any part of the body can develop cancer, which tend to spread to the other parts of the body. Gastric cancer is a type of cancer that starts in the stomach. The gastric cancer is also called as the stomach cancer. The progression of this cancer is slow. The advancement in the growth of the tumor leads serious complications. The treatment depends on the stage of the cancer. The early diagnosis helps in improving the survival rates.


Market Dynamics: Gastric Cancer Testing Market

Increase in the prevalence of gastrointestinal tumors, adenocarcinoma, lymphoma etc. and change in the lifestyles are majorly driving the growth of the gastric cancer testing market. Various factors such as increasing alcohol consumption and smoking is anticipated to drive the growth of the gastric cancer testing market. However, the stringent government regulations for the approval would hamper the growth of the market. The high cost involved in the testing would restrain the growth of the gastric cancer testing market.


Free sample of this report is available upon request @


Market Scope: Gastric Cancer Testing Market

Gastric cancer testing market is segmented based on the test, product, gastric cancer type and end user.

Based on the test, the market is segmented into the following:

·        Immunohistochemistry (IHC)

·        Fluorescent in situ hybridization (FISH)


Based on the product, the market is segmented into the following:

·        Kits

·        Reagents


Based on the gastric cancer type, the market is segmented into the following:

·        Adenocarcinoma

·        Lymphoma

·        Gastrointestinal stromal tumor (GIST)

·        Carcinoid tumor


Based on the end user, the market is segmented into the following:

·        Hospitals

·        Diagnostic centers

·        Others


Free TOC of this report is available upon request @


Regional Analysis:  Gastric Cancer Testing Market

Geographically, global gastric cancer testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Asia Pacific gastric cancer testing market is the dominant market when compared with that of the other regional markets. According to the World Cancer Research Fund International, Japan has held the largest share of around 24.7% in the global stomach cancer treatment market owing to its higher consumption of the spicy and salty food. Also, the other countries such as China which accounted for about 29.9% and South Korea which accounted for 41.4% has higher rates of incidence in the stomach cancer. According to the World Health Organization (WHO), there are 723,000 cancer related deaths caused by the stomach cancer all across the globe. The North America and the European region are expected to grow at slow pace over the forecast period.


Need more information about this report @


Competition Assessment: Gastric Cancer Testing Market

Some of the players in the global gastric cancer testing market include:

·        Agilent Technologies, Inc. (U.S.)

·        Thermo Fisher Scientific, Inc. (U.S.)

·        Illumina, Inc. (Denmark)

·        Becton, Dickinson and Company (U.S.)

·        GE Healthcare (U.K.)

·        QIAGEN N.V.  (Netherlands)

·        Abbott Laboratories, Inc. (U.S.)

·        Roche Diagnostics (Switzerland)

·        Siemens Healthcare (Germany)

·        Philips Healthcare (U.K.)

·        C.R. Bard, Inc. (U.S.)


Notable Market Developments: Gastric Cancer Testing Market

Ø  In June 2016, Oxford Gene Technology (OGT) has launched extensive catalogue of fluorescence in situ hybridisation (FISH) products with 9 new Cytocell Aquarius probes which includes ETV6 Proximal Probe Green, ETV6 Distal Probe Red, MPO Probe Red, TP53 Probe Green, NUP214 Probe Red, DEK Probe Green, TAS2R1 (5p15.31) Probe Green, Chromosome 9 Satellite III Probe Aqua and Chromosome 15 Alpha Satellite Probe Red.


Get access to full summary @


About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX


Toll Free (US):+1-866-598-1553

Website @

blog comments powered by Disqus è un servizio offerto da Factotum Srl